Skip to main content

Advertisement

SpringerLink
Log in

Post-transplant diabetes mellitus: incidence, predicting factors and outcomes

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

To identify predictors and evaluate outcomes of posttransplant diabetes mellitus (PTDM) and to investigate the effect of treatment modalities on outcomes.

Methods

The database of a tertiary medical center was searched for all adult patients without prior diabetes who underwent lung, liver, or heart transplantation between January 1, 2012 and June 30, 2018. Patients in whom PTDM (defined as HbA1C ≥ 6.5% at least 3 months post transplantation) developed during follow-up (mean 3.32 years) were identified. Risk factors for PTDM, determined by regression analysis and clinical outcomes [all-cause mortality, severe infections, graft loss, and major adverse cardiovascular events (MACE)], were compared between those who developed PTDM and those who did not; in the former, insulin-based therapy was compared with non-insulin regimen.

Results

The cohort included 281 transplant recipients: 158 lung, 109 liver, and 14 heart. PTDM was diagnosed in 60 (21.35%) patients at a mean of 11.3 ± 12.89 months post transplantation. The only significant independent risk factor for PTDM was age (HR 1.028, 95% CI = 1.002–1.054, P = 0.0314). PTDM was associated with higher rates of severe infections (HR 2.565, 95% CI = 1.626–4.050, P < 0.0001), MACE (HR 1.856, 95% CI = 1.013–3.401, P = 0.0454) and death (HR 1.840, 95% CI = 1.024–3.304, P = 0.0413). Recipients treated with insulin-based regimens had a higher risk of severe infections (HR 2.579, 95% CI = 1.640–4.055, P < 0.0001), MACE (1.925, 95% CI = 1.074–3.451, P = 0.0278) and death (HR 1.960, 95% CI = 1.071–3.586, P = 0.0291).

Conclusions

PTDM is associated with increased mortality and poor outcomes in lung, liver, and heart transplant recipients. Early identification and aggressive treatment of PTDM and its associated cardiometabolic risk factors may improve outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Q. Ling, X. Xu, H. Xie, K. Wang, P. Xiang, R. Zhuang, T. Shen, J. Wu, W. Wang, S. Zheng, New-onset diabetes after liver transplantation: a national report from China Liver Transplant Registry. Liver Int. 36, 705–712 (2016)

    Article  Google Scholar 

  2. V. Bhat, M. Tazari, K.D. Watt, M. Bhat, New-onset diabetes and preexisting diabetes are associated with comparable reduction in long-term survival after liver transplant: a machine learning approach. Mayo Clin. Proc. 93, 1794–1802 (2018)

    Article  Google Scholar 

  3. C. Lv, Y. Zhang, X. Chen, X. Huang, M. Xue, Q. Sun, T. Wang, J. Liang, S. He, J. Gao, J. Zhou, M. Yu, J. Fan, X. Gao, New-onset diabetes after liver transplantation and its impact on complications and patient survival. J. Diabetes 7, 881–890 (2015)

    Article  CAS  Google Scholar 

  4. H.T. Kuo, M.S. Sampaio, X. Ye, P. Reddy, P. Martin, S. Bunnapradist, Risk factors for newonset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation 89, 1134–1140 (2010)

    Article  Google Scholar 

  5. A.D. Yadav, Y.H. Chang, B.A. Aqel, T.J. Byrne, H.A. Chakkera, D.D. Douglas, D.C. Mulligan, J. Rakela, H.E. Vargas, E.J. Carey, New onset diabetes mellitus in living donor versus deceased donor liver transplant recipients: analysis of the UNOS/OPTN database. J. Transplant. 2013, 269096 (2013)

    Article  Google Scholar 

  6. M. Zhang, Y. Han, Y. Yuan, J. Cai, J. Zhang, Y. Wang, H. Xiang, H. Zhou, Risk factors for new-onset diabetes mellitus after heart transplantation in Chinese patients: a single center experience. Ann. Nutr. Metab. 74, 331–338 (2019)

    Article  CAS  Google Scholar 

  7. J. Saraiva, E. Sola, D. Prieto, M.J. Antunes, Diabetes as an outcome predictor after heart transplantation. Interact. Cardiovasc. Thorac. Surg. 13, 499–504 (2011)

    Article  Google Scholar 

  8. X. Ye, H.T. Kuo, M.S. Sampaio, Y. Jiang, P. Reddy, S. Bunnapradist, Risk factors for development of new-onset diabetes mellitus in adult heart transplant recipients. Transplantation 89, 1526–1532 (2010)

    Article  Google Scholar 

  9. J.E. Ollech, M.R. Kramer, N. Peled, A. Ollech, A. Amital, B. Medalion, M. Saute, D. Shitrit, Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors. Eur. J. Cardiothorac. Surg. 33, 844–848 (2008)

    Article  Google Scholar 

  10. K.L. Hackman, G.I. Snell, L.A. Bach, Prevalence and predictors of diabetes after lung transplantation: a prospective, longitudinal study. Diabetes Care. 37, 2919–2925 (2014)

    Article  Google Scholar 

  11. N. Saigi-Morgui, L. Quteineh, P.Y. Bochud, S. Crettol, Z. Kutalik, N.J. Mueller, I. Binet, C. Van Delden, J. Steiger, P. Mohacsi, J.F. Dufour, P.M. Soccal, M. Pascual, C.B. Eap, Swiss Transplant Cohort Study: genetic and clinic predictors of new onset diabetes mellitus after transplantation. Pharmacogenomics J. 19, 53–64 (2019)

    Article  CAS  Google Scholar 

  12. H.J. Kim, S.H. Jung, J.J. Kim, T.J. Yun, J.B. Kim, S.J. Choo, C.H. Chung, J.W. Lee, New-onset diabetes mellitus after heart transplantation—incidence, risk factors and impact on clinical outcome. Circ. J. 81, 806–814 (2017)

    Article  CAS  Google Scholar 

  13. M. Castedal, C. Skoglund, C. Axelson, W. Bennet, Steroid-free immunosuppression with low-dose tacrolimus is safe and significantly reduces the incidence of new-onset diabetes mellitus following liver transplantation. Scand. J. Gastroenterol. 53, 741–747 (2018)

    Article  CAS  Google Scholar 

  14. L. Xie, W. Tang, X. Wang, L. Wang, Y. Lu, T. Lin, Pretransplantation risk factors associated with new-onset diabetes after living-donor kidney transplantation. Transplant. Proc. 48, 3299–3302 (2016)

    Article  CAS  Google Scholar 

  15. M.O. Salifu, F. Tedla, P.V. Murty, S. Aytug, S.I. McFarlane, Challenges in the diagnosis and management of new-onset diabetes after transplantation. Curr. Diab. Rep. 5, 194–199 (2005)

    Article  Google Scholar 

  16. F.C. Mazali, C.A. Lalli, G. Alves-Filho, M. Mazzali, Posttransplant diabetes mellitus: incidence and risk factors. Transplant. Proc. 40, 764–766 (2008)

    Article  Google Scholar 

  17. S. Palepu, G.V. Prasad, New-onset diabetes mellitus after kidney transplantation: current status and future directions. World J. Diabetes 6, 445–455 (2015)

    Article  Google Scholar 

  18. M.G. Cehic, N. Nundall, J.R. Greenfield, P.S. Macdonald, Management strategies for posttransplant diabetes mellitus after heart transplantation: a review. J. Transplant. 2018, 1025893 (2018)

    Article  Google Scholar 

  19. M. Hornum, J.P. Lindahl, B. von Zur‐Mühlen, T. Jenssen, B. Feldt‐Rasmussen, Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation Societies. Transpl. Int. 26, 1049–1060 (2013)

    Article  Google Scholar 

  20. A.R. Soliman, A. Fathy, S. Khashab, N. Shaheen, M.A. Soliman, Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant. Exp. Clin. Transplant. 11, 494–498 (2013)

    Article  Google Scholar 

  21. M. Haidinger, J. Werzowa, M. Hecking, M. Antlanger, G. Stemer, J. Pleiner, C. Kopecky, J.J. Kovarik, D. Döller, G. Pacini, M.D. Säemann, Efficacy and safety of vildagliptin in new‐onset diabetes after kidney transplantation-a randomized, double‐blind, placebo‐controlled trial. Am. J. Transpl. 14, 115–123 (2014)

    Article  CAS  Google Scholar 

  22. A. Sharif, M. Hecking, A.P. de Vries, E. Porrini, M. Hornum, S. Rasoul-Rockenschaub, G. Berlakovich, M. Krebs, A. Kautzky-Willer, G. Schernthaner, P. Marchetti, G. Pacini, A. Ojo, S. Takahara, J.L. Larsen, K. Budde, K. Eller, J. Pascual, A. Jardine, S.J. Bakker, T.G. Valderhaug, T.G. Jenssen, S. Cohney, M.D. Säemann, Proceedings from an International Consensus Meeting on Posttransplantation Diabetes Mellitus: recommendations and future directions. Am. J. Transplant. 14, 1992–2000 (2014)

    Article  CAS  Google Scholar 

  23. L. Cooper, N. Oz, G. Fishman, T. Shohat, R. Rahamimov, E. Mor, H. Green, A. Grossman, New onset diabetes after kidney transplantation is associated with increased mortality—a retrospective cohort study. Diabetes Metab. Res. Rev. 33, e2920 (2017)

    Article  Google Scholar 

  24. S. Kesiraju, P. Paritala, Ch,U.M. Rao, S. Sahariah, New onset of diabetes after transplantationd an overview of epidemiology, mechanism of development and diagnosis. Transpl. Immunol. 30, 52–58 (2014)

    Article  Google Scholar 

  25. V. Shivaswamy, B. Boerner, J. Larsen, Posttransplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocr. Rev. 37, 37–61 (2016)

    Article  CAS  Google Scholar 

  26. R.J. Galindo, A. Wallia, Hyperglycemia and diabetes mellitus following organ transplantation. Curr. Diab. Rep. 16, 14 (2016)

    Article  Google Scholar 

  27. R.D. Yusen, J.D. Christie, L.B. Edwards, A.Y. Kucheryavaya, C. Benden, A.I. Dipchand, F. Dobbels, R. Kirk, L.H. Lund, A.O. Rahmel, J. Stehlik, The registry of the international society for heart and lung transplantation: thirtieth adult lung and heart-lung transplant report–2013; focus theme: age. Am. J. Transplant. 32(10), 965–78 (2013)

    Google Scholar 

  28. S. Baid, A. B. Cosimi, M. L. Farrell, D. A. Schoenfeld, S. Feng, R. T. Chung, N. Tolkoff-Rubin, M. Pascual, Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 72, 1066–1072 (2001)

    Article  CAS  Google Scholar 

  29. K.A. Morbitzer, D.J. Taber, N.A. Pilch, H.B. Meadows, J.N. Fleming, C.F. Bratton, J.W. McGillicuddy, P.K. Baliga, K.D. Chavin, The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin. Transplant. 28, 862–868 (2014)

    Article  CAS  Google Scholar 

  30. J.J. Gaynor, G. Ciancio, G. Guerra, J. Sageshima, L. Hanson, D. Roth, M.J. Goldstein, L. Chen, W. Kupin, A. Mattiazzi, L. Tueros, S. Flores, L.J. Barba, A. Lopez, J. Rivas, P. Ruiz, R. Vianna, G.W. Burke 3rd, Single‐centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new‐onset diabetes after transplant. Diabetologia 58, 334–345 (2015)

    Article  CAS  Google Scholar 

  31. C. Lv, M. Chen, M. Xu, G. Xu, Y. Zhang, S. He, M. Xue, J. Gao, M. Yu, X. Gao, T. Zhu, Influencing factors of new‐onset diabetes after renal transplant and their effect on complications and survival rate. PLoS One 9, e99406 (2014)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine B, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel

    Nadav Mizrahi & Alon Grossman

  2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Nadav Mizrahi, Marius Braun, Tuvia Ben Gal, Dror Rosengarten, Mordechai Reuven Kramer & Alon Grossman

  3. The Liver Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel

    Marius Braun

  4. Department of Cardiology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel

    Tuvia Ben Gal

  5. Pulmonary Division, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel

    Dror Rosengarten & Mordechai Reuven Kramer

Authors
  1. Nadav Mizrahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marius Braun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tuvia Ben Gal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dror Rosengarten
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mordechai Reuven Kramer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alon Grossman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nadav Mizrahi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study was approved by the institutional ethics board.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mizrahi, N., Braun, M., Ben Gal, T. et al. Post-transplant diabetes mellitus: incidence, predicting factors and outcomes. Endocrine 69, 303–309 (2020). https://doi.org/10.1007/s12020-020-02339-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-020-02339-9

Keywords

Search

Navigation